Effect of Combined Prednisolone, Epidural Analgesia, and Indomethacin on the Systemic Response After Colonic Surgery

Archives of Surgery

Volumn 127, Issue 3, 1992, Pages 325-331

  Schulze, Svend ^a   Sommer, Peter ^a   Bigler, Dennis ^a   Honnens, Mette ^a   Shenkin, Allan ^b   Cruickshank, Anne M ^b   Bukhave, Klaus ^c   Kehlet, Henrik ^d  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; C REACTIVE PROTEIN; INDOMETACIN; INTERLEUKIN 6; METHYLPREDNISOLONE SODIUM SUCCINATE; MORPHINE DERIVATIVE; PARACETAMOL; PREDNISOLONE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

AGED; CLINICAL ARTICLE; COLON SURGERY; CONFERENCE PAPER; DOSE RESPONSE; DRUG MIXTURE; ELECTIVE SURGERY; EPIDURAL ANESTHESIA; FEMALE; HUMAN; HYPERTHERMIA; LUNG FUNCTION; MALE; MOBILIZATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL;

ACETAMINOPHEN; ACTIVITIES OF DAILY LIVING; AGED; ANALGESIA, EPIDURAL; BODY TEMPERATURE; BUPIVACAINE; C-REACTIVE PROTEIN; COLONIC DISEASES; DRUG THERAPY, COMBINATION; FATIGUE; FEMALE; HUMAN; INDOMETHACIN; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; METHYLPREDNISOLONE HEMISUCCINATE; MORPHINE; NERVE BLOCK; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PROSTAGLANDINS E; RESPIRATORY FUNCTION TESTS; SUPPORT, NON-U.S. GOV'T;

EID: 0026575565     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1992.01420030095018     Document Type: Article

References (65)

1. Gordon AH. Other injury-mediated metabolic changes. In: Gordon AH, Koj A, eds. The Acute-Phase Response to Injury and Infection. Amsterdam, the Netherlands: Elsevier Science Publishers; 1985:121-136.
2. Douglas RG, Shaw JHF. Metabolic response to sepsis and trauma. Br J Surg. 1989;76:115-122.
3. Larsen GL, Henson PM. Mediators in inflammation. Annu Rev Immunol. 1983;1:335-359.
4. Kehlet H, Schulze S. Modification of the general response to injury-pharmacological and clinical aspects. In: Little RA, Frayn KN, eds. The Scientific Basis and Care of the Critically III. Manchester, England: University Press; 1986:153-168.
5. Fantone JC, Marasco WA, Elgas LJ, Ward PA. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. Am J Pathol. 1984;115:9-16.
6. Mertin J, Stackpoole A, Shumway SJ. Prostaglandins and cell-mediated immunity. Transplantation. 1984;37:396-402.
7. Faist E, Ertel W, Cohnert T, Huber P, Inthorn D, Heberer G. Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma. J Trauma. 1990;30:8-18.
8. Clowes GHA, George BC, Villee CA, Saravis CA. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med. 1983;308:545-552.
9. Michie HR, Wilmore DW. Sepsis, signals, and surgical sequelae (a hypothesis). Arch Surg. 1990;125:531-536.
10. Horgan PG, Mannick JA, Dubravec DB, Rodrick ML. Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis in a murine burn model. Br J Surg. 1990;77:401-404.
11. Fong Y, Moldawer LL, Shires GT, Lowry SF. The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet. 1990;170:363-378.
12. Braquet P, Hosford D. The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS). Prog Clin Biol Res. 1989;308:425-439.
13. Kehlet H. Modification of response to surgery by neural blockade: clinical implications. In: Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. Boston, Mass: JB Lippincott; 1987:145-188.
14. Heindorff H, Schulze S, Mogensen T, Almdal T, Kehlet H, Vilstrup H. Prevention of postoperative increase in urea synthesis and amino acid clearance by hormonal and neural blockade. Surgery. In press.
15. Scott NB, Kehlet H. Regional anaesthesia and surgical morbidity. Br J Surg. 1988;75:299-304.
16. Kehlet H. Neural release mechanisms in the response to injury. In: Risberg E, Aasen AO, eds. New Aspects of Surgical Pathophysiology. New York, NY: Harwood Academic Publisher; 1990:77-90.
17. Schulze S, Roikjær O, Hasselstrom L, Jensen NH, Kehlet H. Epidural bupivacaine and morphine plus systemic indomethacin eliminates pain but not the systemic response and convalescence after cholecystectomy. Surgery. 1988;103:321-327.
18. Schulze S, Moller IW, Bang U, Rye B, Kehlet H. Effect of combined prednisolone, epidural analgesia and indomethacin on pain, systemic response and convalescence after cholecystectomy. Acta Chir Scand. 1990;156:203-209.
19. Coulie PG, Cayphas S, Vink A, Uyttenhove C, Van Snick J. Interleukin-HP1-related hybridoma and plasmacytoma growth factors induced by lipopolysaccharide in vivo. Eur J Immunol. 1987;17:1217-1220.
20. Bukhave K, Rask-Madsen J. Prostaglandin E2 in jejunal fluids and its potential diagnostic value for selecting patients with indomethacin-sensitive diarrhoea. Eur J Clin Invest. 1981;11:191-197.
21. Bukhave K, Gren K, Rask-Madsen J. Comparison of radioimmunological determinations with gas chromatography mass spectrometry dosage: a study of PGE2 and PGF2 alpha in gastrointestinal fluids. Biomed Mass Spectrom. 1983;10:265-268.
22. Huskisson EC. Measurement of pain. Lancet. 1974;2:1127-1131.
23. Christensen T, BendixT, Kehlet H. Fatigue and cardio-respiratory function following abdominal surgery. Br J Surg. 1983;69:417-419.
24. Krantz T, Wolff C, Hjorts NC, Kehlet H. Assessment of early postoperative convalescence by a simple scoring system. Ugeskr Laeger. 1990;152:1168-1170.
25. Dahl JB, Rosenberg J, Dirkes WE, Mogensen T, Kehlet H. Prevention of postoperative pain by balanced analgesia. Br J Anaesth. 1990;64:518-520.
26. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5:25-44.
27. Fahey JV, Guyre PM, Munck A. Mechanisms of antiinflammatory actions of glucocorticoids. Adv Inflammat Res. 1981;2:21-51.
28. Lundberg D. The pharmacological basis of treatment with high dose corticosteroids in circulatory shock. Acta Chir Scand. 1985;526(suppl):7-12.
29. Raja SN, Meyer RA, Campbell JN. Peripheral mechanisms of somatic pain. Anesthesiology. 1988;68:571-590.
30. Wall PD. The prevention of postoperative pain. Pain. 1988;33:289-290.
31. Dinarello CA, Cannon JG, Wolff SM. New concepts on the pathogenesis of fever. Rev Infect Dis. 1988;10:168-189.
32. Schulze S, Drenck NE, Hjorts E, Kehlet H. Influence of combined neural blockade, H1- and H2 receptor and serotonin2-receptor blockade, indomethacin and tranexamic acid on leucocyte, temperature and acute phase protein response to surgery. Acta Chir Scand. 1988;154:329-333.
33. Russo-Marie F, Paing M, Duval D. Involvement of glucocorticoid receptors in steroid-induced inhibition of prostaglandin secretion. J Biol Chem. 1979;254:8498-8504.
34. Besedovsky H, Rey AD, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986;233:652-654.
35. Beutler B, Cerami A. Cachectin: more than just a tumor necrosis factor. N Engl J Med. 1987;316:379-385.
36. Kelso A, Munck A. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J Immunol. 1984;133:784-791.
37. Woloski BMRNJ, Smith EM, Meyer WJ, Fuller GM, Blalock JE. Corticotropin-releasing activity of monokines. Science. 1985;230:1035-1037.
38. Sundberg A, Wattwil M, Arvill A. Respiratory effects of high thoracic epidural anaesthesia. Acta Anaesthesiol Scand. 1986;30:215-217.
39. Sydow FW. The influence of anesthesia and postoperative analgesic management on lung function. Acta Chir Scand. 1988;550(suppl):159-168.
40. Hendolin H, Lahtinen J, Lansimies T, Tuppurainen T, Partanen K. The effect of thoracic epidural analgesia on respiratory function after cholecystectomy. Acta Anaesthesiol Scand. 1987;31:645-651.
41. Cuschieri RJ, Morran CG, Howie JC, McArdle CS. Postoperative pain and pulmonary complications: comparison of three analgesic regimens. Br J Surg. 1985;72:495-498.
42. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983;220:568-575.
43. Vogt W. Anaphylatoxins: possible roles in disease. Complement. 1986;3:177-188.
44. Von Eickstedt KW. Corticotrophins and corticosteroids. In: Dukes MNG, ed. Meyler's Side Effects of Drugs. Amsterdam, the Netherlands: Elsevier Science Publishers; 1984:727-743.
45. Haynes RC, Murad F. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of adrenocortical steroid biosynthesis. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, NY: Macmillan Publishing Co Inc; 1985;1459-1489.
46. Dale DC, Fauci AS, Guerry D, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man. J Clin Invest. 1975;56:808-813.
47. Michie HR, Spriggs DR, Manogue KR, et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery. 1988;104:280-286.
48. Berger M, Wetzler EM, Wallis RS. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood. 1988;71:151-158.
49. Flores E, Drabik M, Bistrian BR, Istfan N, Blackburn GL, Dinarello CA. Acute phase response to human recombinant mediators. Surg Forum. 1986;37:28-30.
50. Ulich TR, Castillo J, Keys M, Granger GA, Ni RX. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alfa—induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol. 1987;139:3406-3415.
51. GauldieJ, Richards C, Harnish D, Lansdorp P, Baumann H. Interferon beta2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987;84:7251-7255.
52. Castell JV, Gomez-Lechon MJ, David M, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989;242:237-239.
53. O'Garra A. Interleukins and the immune system. Lancet. 1989;1:943-946.
54. Shenkin A, Fraser WD, Series J, et al. The serum interleukin 6 response to elective surgery. Lymphokine Res. 1989;8:123-127.
55. Cruickshank AM, Fraser WD, Burns HJG, Van Damme J, Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci. 1990;79:161-165.
56. Gauldie J, Sauder DN, McAdam KPWJ, Dinarello CA. Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunology. 1987;60:203-207.
57. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest. 1986;78:1349-1354.
58. Cruickshank AM, Hansell DT, Burns HJG, Shenkin A. Effect of nutritional status on acute phase protein response to elective surgery. Br J Surg. 1989;76:165-168.
59. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet. 1989;1:1122-1126.
60. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987;1:355-357.
61. Marano MA, Fong Y, Moldawer LL, et al. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet. 1990;170:32-38.
62. Fong Y, Lowry SF. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol. 1990;55:157-170.
63. Begley CJ, Ogletree ML, Meyrick BO, Brigham KL. Modification of pulmonary responses to endotoxemia in awake sheep by steroidal and nonsteroidal anti-inflammatory agents. Am Rev Respir Dis. 1984;130:1140-1146.
64. Hammerschmidt DE, Flynn PJ, Coppo PA, Skubitz KM, Jakob HS. Synergy among agents inhibiting granulocyte aggregation. Inflammation. 1982;6:169-176.
65. Almqvist PM, Ekstrom B, Kuenzig M, Haglund U, Schwartz SI. Increased survival of endotoxin-injected dogs treated with methylprednisolone, naloxone, and ibuprofen. Circ Shock. 1984;14:129-136.